Takeshi Sano

Assistant Professor

Kyoto University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Imaging Medical Imaging professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takeshi Sano is an Assistant Professor at Kyoto University in Japan. His research areas primarily focus on urothelial cancer, including diagnostic techniques and treatment strategies such as photodynamic diagnosis and immune checkpoint inhibition. He has authored several articles examining the clinical utility of biomarkers and addressing challenges in managing bladder cancer.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Takashi Kobayashi

JAPAN

View details

Shusuke Akamatsu

JAPAN

View details

Takayuki Sumiyoshi

Kyoto University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takeshi Sano

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer

Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanism

Pathological Analysis of False‐Positive Samples in Photodynamic Diagnosis of Bladder Cancer According to a History of Intravesical Bacillus Calmette‐Guérin Therapy

Reply to Ruohui Huang and Liang Peng’s letter to the editor for the article “diagnostic performance of photodynamic diagnosis with oral 5-aminolevulinic acid for upper tract- and bladder urothelial carcinoma: a single-centre, retrospective analysis”

Successful Transurethral Resection of Recurrent Tumor in an Isolated Bladder Diverticulum Under Transrectal Ultrasound Guidance

Diagnostic performance of photodynamic diagnosis with oral 5-aminolevulinic acid for upper tract- and bladder urothelial carcinoma: a single-centre, retrospective analysis

Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non‐muscle‐invasive bladder cancer: A retrospective multicenter study

Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma

Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias

Paraurachal paraganglioma

A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome

Incomplete sagittal septum of the bladder with cystolithiasis

Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture

IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.

IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab

Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function.

Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function

Collaborators (3)

Takashi Kobayashi

Shusuke Akamatsu

Takayuki Sumiyoshi

Make your next move.